Synopsys (SNPS) Cash & Equivalents (2009 - 2026)

Synopsys' Cash & Equivalents history runs 18 years deep, the most recent figure standing at $2.1 billion for Q1 2026.

• Quarterly Cash & Equivalents fell 41.78% year-over-year to $2.1 billion in Q1 2026, while the trailing twelve-month figure through Jan 2026 was $2.1 billion (down 41.78% YoY) and the FY2025 annual result came in at $3.0 billion, down 24.05% from the prior year.
• Cash & Equivalents was $2.1 billion for Q1 2026 at Synopsys, down from $3.0 billion in the prior quarter.
• Across five years, Cash & Equivalents topped out at $14.3 billion in Q2 2025 and bottomed at $1.1 billion in Q1 2024.
• A 5-year average of $2.7 billion and a median of $1.6 billion in 2022 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2025 — Cash & Equivalents jumped 847.64% — and 2026, when it tumbled 41.78%.
• Synopsys' Cash & Equivalents stood at $1.4 billion in 2022, then rose by 0.99% to $1.4 billion in 2023, then soared by 171.88% to $3.9 billion in 2024, then decreased by 24.05% to $3.0 billion in 2025, then fell by 28.08% to $2.1 billion in 2026.
• Business Quant data shows SNPS's Cash & Equivalents at $2.1 billion in Q1 2026, $3.0 billion in Q4 2025, and $2.6 billion in Q3 2025.